Back to 
ProShare Advisors LLC
ProShare Advisors LLC
KNSA
Showing 0 of 6 quarters
Position history for ProShare Advisors LLC's holdings in KINIKSA PHARMACEUTICALS-A
No. ProShare Advisors exited its KNSA (Kiniksa Pharmaceuticals) position in Q1 2022. Its Q4 2021 13F listed 11,143 shares worth $131,000. ProShare Advisors first reported KNSA in Q4 2020 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.